| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13D · 1 security · may seek to influence control | ||||||
|
Amneal Pharmaceuticals, Inc.
13D/A
AMRX · 03168L105
|
5.4% |
3/26/2026
Event 12/31/2025
|
||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.